Cancer (Oncology)
Cancer (Oncology)
Tagrisso 80® Osimertinib Tablets
Osimertinib 80mg
- Composition
- Osimertinib 80mg
- Dosage form
- Tablet
- Pack size
- Strip of 10 Tablet
- Manufacturer
- Astrazeneca
- Also known as
- Tagrisso
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Tagrisso 80 mg contains osimertinib and is used to treat EGFR mutation-positive non-small cell lung cancer. It may be prescribed as postoperative treatment or for advanced or metastatic disease, depending on the tumour's characteristics and the patient's treatment plan
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Licensed wholesalerForm 20B & 21B, Delhi
Discreet packagingPlain outer box, no product labels
Worldwide shippingDirect to you or your customer
Related products
Cancer (Oncology)
Cancer (Oncology)
Tipanat 15® Tipiracil and Trifluridine Tablets
Tipiracil 6.14mg+ Trifluridine 15mg
Tablet · Bottle of 20 Tablets
Cancer (Oncology)
Cancer (Oncology)